Search research articles
Contact Us
Filters
Showing results (21-30 of 115) with videos related to
Page
of 12
Sort By:
Journal of Neuroimmunology
|
November 21, 2017
Vitamin D<sub>3</sub> supplementation and the IL-2/IL-2R pathway in multiple sclerosis: Attenuation of progressive disturbances?
Linda Rolf, Anne-Hilde Muris, Ruud Theunissen, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
November 25, 2015
A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis
Anne-Hilde Muris, Linda Rolf, Kelly Broen, et al.
Journal of Rehabilitation Medicine
|
June 10, 2017
Mindfulness-based cognitive therapy for severely fatigued multiple sclerosis patients: A waiting list controlled study
Alexandra E W Hoogerwerf, Yvonne Bol, Jill Lobbestael, et al.
Journal of Immunological Methods
|
May 9, 2012
Intracellular IL-10 detection in T cells by flowcytometry: the use of protein transport inhibitors revisited
Anne-Hilde Muris, Jan Damoiseaux, Joost Smolders, et al.
Journal of the Neurological Sciences
|
October 25, 2016
Prolonged-release fampridine treatment improved subject-reported impact of multiple sclerosis: Item-level analysis of the MSIS-29
Claudio Gasperini, Raymond Hupperts, Jan Lycke, et al.
Annals of the New York Academy of Sciences
|
September 18, 2009
Prevalence of anticardiolipin antibodies in patient cohorts with distinct clinical manifestations of the antiphospholipid syndrome
Jan Damoiseaux, Louis Peeters, Raymond Hupperts, et al.
Expert Opinion on Drug Delivery
|
November 29, 2014
Multiple sclerosis patients treated with intramuscular IFN-β-1a autoinjector in a real-world setting: prospective evaluation of treatment persistence, adherence, quality of life and satisfaction
Raymond Hupperts, Veit Becker, Janne Friedrich, et al.
Plos One
|
December 2, 2021
Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis
Max Mimpen, Linda Rolf, Geert Poelmans, et al.
Acta Neurologica Scandinavica
|
October 29, 2019
Vitamin D<sub>3</sub> supplementation and neurofilament light chain in multiple sclerosis
Joost Smolders, Max Mimpen, Johanna Oechtering, et al.
Plos One
|
December 24, 2010
Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis
Joost Smolders, Evelyn Peelen, Mariëlle Thewissen, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 115) with videos related to
Sort By:
Page
of 12
Journal of Neuroimmunology
|
November 21, 2017
Vitamin D<sub>3</sub> supplementation and the IL-2/IL-2R pathway in multiple sclerosis: Attenuation of progressive disturbances?
Linda Rolf, Anne-Hilde Muris, Ruud Theunissen, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
November 25, 2015
A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis
Anne-Hilde Muris, Linda Rolf, Kelly Broen, et al.
Journal of Rehabilitation Medicine
|
June 10, 2017
Mindfulness-based cognitive therapy for severely fatigued multiple sclerosis patients: A waiting list controlled study
Alexandra E W Hoogerwerf, Yvonne Bol, Jill Lobbestael, et al.
Journal of Immunological Methods
|
May 9, 2012
Intracellular IL-10 detection in T cells by flowcytometry: the use of protein transport inhibitors revisited
Anne-Hilde Muris, Jan Damoiseaux, Joost Smolders, et al.
Journal of the Neurological Sciences
|
October 25, 2016
Prolonged-release fampridine treatment improved subject-reported impact of multiple sclerosis: Item-level analysis of the MSIS-29
Claudio Gasperini, Raymond Hupperts, Jan Lycke, et al.
Annals of the New York Academy of Sciences
|
September 18, 2009
Prevalence of anticardiolipin antibodies in patient cohorts with distinct clinical manifestations of the antiphospholipid syndrome
Jan Damoiseaux, Louis Peeters, Raymond Hupperts, et al.
Expert Opinion on Drug Delivery
|
November 29, 2014
Multiple sclerosis patients treated with intramuscular IFN-β-1a autoinjector in a real-world setting: prospective evaluation of treatment persistence, adherence, quality of life and satisfaction
Raymond Hupperts, Veit Becker, Janne Friedrich, et al.
Plos One
|
December 2, 2021
Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis
Max Mimpen, Linda Rolf, Geert Poelmans, et al.
Acta Neurologica Scandinavica
|
October 29, 2019
Vitamin D<sub>3</sub> supplementation and neurofilament light chain in multiple sclerosis
Joost Smolders, Max Mimpen, Johanna Oechtering, et al.
Plos One
|
December 24, 2010
Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis
Joost Smolders, Evelyn Peelen, Mariëlle Thewissen, et al.
Page
of 12